Company information:
Pbd Biotech Limited (No: 08898572)
Address: GROSVENOR HOUSE, 11, ST. PAULS SQUARE, BIRMINGHAM, WEST MIDLANDS, B3 1RB, ENGLAND
Status: Active
Incorporated: 17-Feb-2014
Accounts Next Due: 30-Nov-2024
Next Confirmation Statement Due: 03-Mar-2025
Industry Class: 74909 - Other professional, scientific and technical activities n.e.c.
Current Director: BERWYN EWART CLARKE ( DOB: Sep-1956 From: Feb-2014 )
Current Director: GEOFFREY JAMES GOWER ( DOB: Dec-1955 From: Dec-2017 )
Current Director: THOMAS MICHAEL CURTIS GREEN ( DOB: Feb-1966 From: Sep-2017 )
Current Director: THOMAS MICHAEL CURTIS GREEN ( DOB: Feb-1966 From: Sep-2017 )
Current Director: CATHERINE ELIZABETH REES ( DOB: Jan-1961 From: Feb-2014 )
Current Director: MARIE ROSKROW ( DOB: Oct-1965 From: Jan-2023 )
Current Director: BENJAMIN MICHAEL CONNOR SWIFT ( DOB: Aug-1988 From: Feb-2014 )
Current Director: JANE THEAKER ( DOB: Mar-1968 From: Jan-2022 )
Current Director: JONATHAN DAVID YEWDALL ( DOB: Jan-1966 From: Dec-2021 )
Current Secretary: ADAUXI LIMITED ( From: Jan-2020 )
Current Secretary: ADAUXI LIMITED ( From: Jan-2020 )
Resigned Director: IAN RICHARD ALLEN CHRISTOPHER ( DOB: Feb-1966 From: Feb-2014 To: Mar-2017 )
Resigned Director: MARK ALAN HAMMOND ( DOB: Jun-1974 From: Mar-2019 To: Dec-2021 )
Resigned Secretary: IAN RICHARD ALLEN CHRISTOPHER ( From: Jan-2016 To: Jan-2018 )
Resigned Secretary: SAMANTHA ANNE SMART ( From: Feb-2018 To: Jan-2020 )
Persons of Significant Control:
Dr Berwyn Ewart Clarke, ADAUXI LTD, Wellington House 90-92 Butt Road, Colchester, Essex, CO3 3DA, England: Ownership of shares – More than 25% but not more than 50% (Notified: 2016-04-06, Ceased: 2018-08-24)
Company Accounts Summary (£)
| Item | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | Chart |
|---|---|---|---|---|---|---|---|---|---|---|
| Current assets | 1,177 | 3,464 | 140,393 | 178,555 | 155,302 | 2,254,338 | 1,581,425 | 2,422,371 | 568,809 | 1177.0,3464.0,140393.0,178555.0,155302.0,2254338.0,1581425.0,2422371.0,568809.0 |
| Current assets / Debtors | 200 | 2,599 | 12,289 | 19,924 | 27,331 | 62,848 | 104,495 | 225,685 | 241,298 | 200.0,2599.0,12289.0,19924.0,27331.0,62848.0,104495.0,225685.0,241298.0 |
| Current assets / Cash at bank and on hand | 977 | 865 | 128,104 | 158,631 | 127,971 | 2,191,490 | 1,434,861 | 2,196,686 | 327,511 | 977.0,865.0,128104.0,158631.0,127971.0,2191490.0,1434861.0,2196686.0,327511.0 |
| Net current assets (liabilities) | -629 | -17,477 | 57,220 | 142,026 | 120,802 | 2,152,984 | 1,336,182 | 2,211,967 | 416,313 | -629.0,-17477.0,57220.0,142026.0,120802.0,2152984.0,1336182.0,2211967.0,416313.0 |
| Net assets (liabilities) | -629 | -17,477 | 62,499 | 146,900 | 124,161 | 330,426 | -661,071 | 2,367,803 | 562,152 | -629.0,-17477.0,62499.0,146900.0,124161.0,330426.0,-661071.0,2367803.0,562152.0 |
| Equity / share capital and reserves | -629 | -17,477 | 62,499 | 146,900 | 124,161 | 330,426 | -661,071 | -629.0,-17477.0,62499.0,146900.0,124161.0,330426.0,-661071.0,0.0,0.0 |